PT1812046E - Mimeticorpos de ligação a receptor de melanocortina, composições, métodos e utilizações - Google Patents

Mimeticorpos de ligação a receptor de melanocortina, composições, métodos e utilizações Download PDF

Info

Publication number: PT1812046E
Authority: PT; Portugal
Prior art keywords: methods; receptor binding; compositions; melanocortin receptor; mimetibodies
Prior art date: 2004-10-25

Application number

PT05819741T

Other languages

English (en)

Inventor

Chichi Huang

Mark Cunningham

Vedrana Stojanovic-Susulic

Karyn O'neil

Jeffrey Luo

Original Assignee

Centocor Ortho Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-25

Filing date

2005-10-25

Publication date

2011-06-28

2005-10-25 Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc

2011-06-28 Publication of PT1812046E publication Critical patent/PT1812046E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Endocrinology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Obesity (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Emergency Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PT05819741T 2004-10-25 2005-10-25 Mimeticorpos de ligação a receptor de melanocortina, composições, métodos e utilizações PT1812046E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US62196004P	2004-10-25	2004-10-25

Publications (1)

Publication Number	Publication Date
PT1812046E true PT1812046E (pt)	2011-06-28

Family

ID=36228385

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT05819741T PT1812046E (pt)	2004-10-25	2005-10-25	Mimeticorpos de ligação a receptor de melanocortina, composições, métodos e utilizações

Country Status (28)

Country	Link
US (1)	US20060105951A1 (pt)
EP (1)	EP1812046B1 (pt)
JP (1)	JP2008517605A (pt)
KR (1)	KR101255140B1 (pt)
CN (1)	CN101437540B (pt)
AT (1)	ATE501731T1 (pt)
AU (1)	AU2005299440B2 (pt)
BR (1)	BRPI0518411A2 (pt)
CA (1)	CA2585287A1 (pt)
CY (1)	CY1111486T1 (pt)
DE (1)	DE602005026970D1 (pt)
DK (1)	DK1812046T3 (pt)
EA (1)	EA200700944A1 (pt)
EC (1)	ECSP077416A (pt)
ES (1)	ES2363023T3 (pt)
HR (1)	HRP20110405T1 (pt)
IL (1)	IL182683A0 (pt)
MA (1)	MA28943B1 (pt)
ME (1)	ME01234B (pt)
MX (1)	MX2007004974A (pt)
NO (1)	NO20072499L (pt)
PL (1)	PL1812046T3 (pt)
PT (1)	PT1812046E (pt)
RS (1)	RS51789B (pt)
SI (1)	SI1812046T1 (pt)
TN (1)	TNSN07157A1 (pt)
WO (1)	WO2006047535A2 (pt)
ZA (1)	ZA200704260B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7910101B2 (en) *	2004-10-25	2011-03-22	Centocor, Inc.	Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) *	2005-10-07	2010-09-07	Codman & Shurtleff, Inc.	Implantable pump for protein delivery for obesity control by drug infusion into the brain
US20090305960A1 (en) *	2008-06-09	2009-12-10	Palatin Technologies, Inc	Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
EP2300036B1 (en)	2008-06-09	2017-04-05	Palatin Technologies, Inc.	Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US8614185B2 (en) *	2009-05-04	2013-12-24	Centocor Ortho Biotech Inc.	Fusion proteins of alpha-MSH derivatives and Fc
UY32690A (es)	2009-06-08	2011-01-31	Astrazeneca Ab	Péptidos específicos para receptores de melanocortina
EP2440572B1 (en)	2009-06-08	2017-04-05	Palatin Technologies, Inc.	Lactam-bridged melanocortin receptor-specific peptides
NZ596617A (en)	2009-06-08	2014-04-30	Palatin Technologies Inc	Melanocortin receptor-specific peptides
CA2781405A1 (en)	2009-11-23	2011-05-26	Palatin Technologies, Inc.	Melanocortin-1 receptor-specific linear peptides
NZ599774A (en)	2009-11-23	2014-11-28	Palatin Technologies Inc	Melanocortin-1 receptor-specific cyclic peptides
JP2020141710A (ja) *	2011-07-06	2020-09-10	ゲンマブエー／エス	抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
CN113272330B (zh) *	2019-03-02	2024-07-26	南通壹宸生物医药科技有限公司	一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA01005818A (es) *	1998-12-09	2003-07-21	Eleanor Rooseveltl Inst	Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas.
WO2002006316A2 (en) *	2000-07-14	2002-01-24	Zycos, Inc.	Alpha-msh related compounds and methods of use
JP2006504406A (ja) *	2002-06-28	2006-02-09	セントカー・インコーポレーテツド	哺乳動物のｃｈ１欠失ミメティボディ、組成物、方法および使用
KR20050033563A (ko) *	2002-06-28	2005-04-12	센토코 인코포레이티드	포유동물 ｅｐｏ 모방 ｃｈ1 결실된 모방체, 조성물, 방법및 용도
WO2005097175A2 (en) *	2004-03-31	2005-10-20	Centocor, Inc.	Human glp-1 mimetibodies, compositions, methods and uses

2005
- 2005-10-25 ME MEP-2011-85A patent/ME01234B/me unknown
- 2005-10-25 KR KR1020077011487A patent/KR101255140B1/ko not_active Expired - Fee Related
- 2005-10-25 HR HR20110405T patent/HRP20110405T1/hr unknown
- 2005-10-25 EP EP05819741A patent/EP1812046B1/en not_active Expired - Lifetime
- 2005-10-25 PT PT05819741T patent/PT1812046E/pt unknown
- 2005-10-25 BR BRPI0518411-8A patent/BRPI0518411A2/pt not_active IP Right Cessation
- 2005-10-25 MX MX2007004974A patent/MX2007004974A/es unknown
- 2005-10-25 CN CN2005800447902A patent/CN101437540B/zh not_active Expired - Fee Related
- 2005-10-25 WO PCT/US2005/038431 patent/WO2006047535A2/en not_active Ceased
- 2005-10-25 JP JP2007538172A patent/JP2008517605A/ja active Pending
- 2005-10-25 DK DK05819741.9T patent/DK1812046T3/da active
- 2005-10-25 AT AT05819741T patent/ATE501731T1/de active
- 2005-10-25 CA CA002585287A patent/CA2585287A1/en not_active Abandoned
- 2005-10-25 PL PL05819741T patent/PL1812046T3/pl unknown
- 2005-10-25 US US11/257,851 patent/US20060105951A1/en not_active Abandoned
- 2005-10-25 DE DE602005026970T patent/DE602005026970D1/de not_active Expired - Lifetime
- 2005-10-25 AU AU2005299440A patent/AU2005299440B2/en not_active Ceased
- 2005-10-25 EA EA200700944A patent/EA200700944A1/ru unknown
- 2005-10-25 ES ES05819741T patent/ES2363023T3/es not_active Expired - Lifetime
- 2005-10-25 RS RS20110230A patent/RS51789B/sr unknown
- 2005-10-25 SI SI200531295T patent/SI1812046T1/sl unknown
2007
- 2007-04-19 IL IL182683A patent/IL182683A0/en unknown
- 2007-04-23 MA MA29843A patent/MA28943B1/fr unknown
- 2007-04-24 TN TNP2007000157A patent/TNSN07157A1/fr unknown
- 2007-04-25 EC EC2007007416A patent/ECSP077416A/es unknown
- 2007-05-15 NO NO20072499A patent/NO20072499L/no not_active Application Discontinuation
- 2007-05-24 ZA ZA200704260A patent/ZA200704260B/xx unknown
2011
- 2011-05-23 CY CY20111100502T patent/CY1111486T1/el unknown

Also Published As

Publication number	Publication date
KR20070085416A (ko)	2007-08-27
CY1111486T1 (el)	2015-08-05
ES2363023T3 (es)	2011-07-19
TNSN07157A1 (en)	2008-11-21
CN101437540A (zh)	2009-05-20
EP1812046A2 (en)	2007-08-01
ATE501731T1 (de)	2011-04-15
PL1812046T3 (pl)	2011-08-31
JP2008517605A (ja)	2008-05-29
IL182683A0 (en)	2007-09-20
MA28943B1 (fr)	2007-10-01
CA2585287A1 (en)	2006-05-04
EP1812046B1 (en)	2011-03-16
WO2006047535A3 (en)	2008-09-04
HK1106445A1 (en)	2008-03-14
MX2007004974A (es)	2007-10-17
KR101255140B1 (ko)	2013-04-22
AU2005299440B2 (en)	2011-12-15
ZA200704260B (en)	2009-03-25
DK1812046T3 (da)	2011-06-06
RS51789B (sr)	2011-12-31
NO20072499L (no)	2007-07-16
ECSP077416A (es)	2007-05-30
SI1812046T1 (sl)	2011-06-30
BRPI0518411A2 (pt)	2008-11-18
AU2005299440A1 (en)	2006-05-04
WO2006047535A2 (en)	2006-05-04
US20060105951A1 (en)	2006-05-18
CN101437540B (zh)	2012-12-19
ME01234B (me)	2013-06-20
EA200700944A1 (ru)	2008-04-28
EP1812046A4 (en)	2009-11-11
DE602005026970D1 (de)	2011-04-28
HRP20110405T1 (hr)	2011-06-30

Publication	Publication Date	Title
ZA200704260B (en)	2009-03-25	Melanocortin receptor binding mimetibodies, compositions, methods and uses
WO2007041635A3 (en)	2008-11-13	Fc variants with optimized fc receptor binding properties
WO2007014169A3 (en)	2007-05-10	Anti-cd26 antibodies and methods of use thereof
WO2006083276A3 (en)	2009-04-16	Interferon-alpha polypeptides and conjugates
WO2006105338A3 (en)	2007-03-29	Fc VARIANTS WITH OPTIMIZED PROPERTIES
TW200611910A (en)	2006-04-16	Interferon-alpha polypeptides and conjugates
IL258718A (en)	2018-06-28	Human anti-23-il antibodies, preparations, methods and uses
WO2006017538A3 (en)	2007-05-18	Hk1-binding proteins
WO2007087139A3 (en)	2007-10-11	MESENCHYMAL STEM CELLS EXPRESSING TNF-α RECEPTOR
TW200631594A (en)	2006-09-16	Toll like receptor 3 antagonists, methods and uses
EP1617802A4 (en)	2007-08-01	CNGH0010 SPECIFIC POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES, COMPOSITIONS, METHODS AND USES
EP2214690A4 (en)	2012-05-09	THE MELANOCORTIN RECEPTOR BINDING MIMIC BODIES, COMPOSITIONS, PROCESSES AND USES
WO2007044083A3 (en)	2009-04-16	Evolved interferon-alpha polypeptides
TW200745159A (en)	2007-12-16	IL-6 binding proteins
MX296535B (es)	2012-02-29	Enzima laccasa novedosa y uso de la misma.
TW200720333A (en)	2007-06-01	Composite materials and methods of making the same
TW200711846A (en)	2007-04-01	Composite materials and methods of making the same
WO2007056760A3 (en)	2008-02-28	Hcv-reactive t cell receptors
SG158098A1 (en)	2010-01-29	Toll like receptor 3 antagonists, methods and uses
WO2005082088A3 (en)	2006-10-05	Functional genomics and gene trapping in haploid or hypodiploid cells
WO2005026207A3 (en)	2005-05-12	Adipocyte complement related protein zacrp12
GB2418913C (en)	2008-08-15	Improved peat substitute.
EP1844065A4 (en)	2008-08-20	POLYPEPTIDE WITH PYRIDOXIN BIOSYNTHESIS FUNCTION, POLYNUCLEOTIDE FOR CODING THE POLYPEPTIDE AND THEIR USE
AU2014210609B9 (en)	2016-07-21	Novel activin receptor and uses thereof